Introduction HS represents a prime candidate to bridge diseases of the integument and comorbid systemic disease, as a chronic inflammatory disease of the pilosebaceous unit characterized by inflammatory nodules, suppuration…
Overview of Patient Population with HS Prior to Initiating Therapy Hidradenitis suppurativa is a clinical diagnosis based on history, physical exams, patterns of recurrence, types of lesions, and scarring. No…
Introduction The imaging support of hidradenitis suppurativa (HS) has been increasing in the last decade due to the development of high-axial-resolution devices that can detect simultaneously and with high definition…
Clinical Manifestation Morphology of Hidradenitis Suppurativa Lesions A key component of the diagnosis of an individual with hidradenitis suppurativa (HS) involves examining for the presence of typical HS morphology. The…
Introduction It is useful to consider the histological findings of hidradenitis suppurativa (HS) lesions in the context of populations at risk for HS to understand the clinical differences observed amongst…
Introduction The average length of time from onset to diagnosis in hidradenitis suppurativa (HS) patients worldwide is 7.2 years. This unfortunate delay is partly because of the nonspecific nature of…
Introduction This chapter will focus on the epidemiology of hidradenitis suppurativa (HS), examining the body of evidence available for estimating the incidence and prevalence of HS, and the distribution of…
Introduction Hidradenitis suppurativa (HS) has a convoluted history with conflicting bodies of knowledge and a complicated pathogenesis. Since HS was first described in the 19th century, it has taken on…
Few snippets Extensor versus flexor skin surfaces: skin over the extensor surface is thicker and darker in color. This is designed to withstand trauma which is more likely to occur…
